AP2000001914A0 - Paroxetine compositions. - Google Patents

Paroxetine compositions.

Info

Publication number: AP2000001914A0
Authority: AP; ARIPO
Prior art keywords: paroxetine; paroxetine compositions; compositions; therapy; absorbed
Prior art date: 1998-03-24

Application number

APAP/P/2000/001914A

Other languages

English (en)

Inventor

Andrew Simon Craig

Neal Ward

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-24

Filing date

1999-03-24

Publication date

2000-09-30

1999-03-24 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2000-09-30 Publication of AP2000001914A0 publication Critical patent/AP2000001914A0/en

Links

AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title abstract 2
AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title abstract 2
229960002296 paroxetine Drugs 0.000 title abstract 2
239000000203 mixture Substances 0.000 title 1
230000015572 biosynthetic process Effects 0.000 abstract 1
239000002775 capsule Substances 0.000 abstract 1
239000000843 powder Substances 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Psychology (AREA)
Inorganic Chemistry (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

APAP/P/2000/001914A 1998-03-24 1999-03-24 Paroxetine compositions. AP2000001914A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9806312.6A GB9806312D0 (en)	1998-03-24	1998-03-24	Novel formulations
PCT/GB1999/000922 WO1999048499A1 (en)	1998-03-24	1999-03-24	Paroxetine compositions

Publications (1)

Publication Number	Publication Date
AP2000001914A0 true AP2000001914A0 (en)	2000-09-30

Family

ID=10829181

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
APAP/P/2000/001914A AP2000001914A0 (en)	1998-03-24	1999-03-24	Paroxetine compositions.

Country Status (20)

Country	Link
EP (1)	EP1063993A1 (no)
JP (1)	JP2002507569A (no)
CN (1)	CN1125639C (no)
AP (1)	AP2000001914A0 (no)
AU (1)	AU754765B2 (no)
BG (1)	BG104865A (no)
BR (1)	BR9908991A (no)
CA (1)	CA2324612A1 (no)
EA (1)	EA003393B1 (no)
GB (1)	GB9806312D0 (no)
HU (1)	HUP0101326A3 (no)
ID (1)	ID26485A (no)
IL (1)	IL138478A0 (no)
NO (1)	NO313404B1 (no)
NZ (1)	NZ506893A (no)
PL (1)	PL343095A1 (no)
SK (1)	SK14102000A3 (no)
TR (1)	TR200002750T2 (no)
WO (1)	WO1999048499A1 (no)
ZA (1)	ZA200005697B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9914600D0 (en) *	1999-06-22	1999-08-25	Smithkline Beecham Plc	Novel,process
DK200100341A (da) *	2001-03-02	2002-09-03	Gea Farmaceutisk Fabrik As	Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
CA2531097C (en) *	2003-07-02	2012-10-09	Abbott Laboratories	Process for preparing formulations of lipid-regulating drugs
US8062664B2 (en)	2003-11-12	2011-11-22	Abbott Laboratories	Process for preparing formulations of lipid-regulating drugs
HU1000278D0 (en) *	2010-05-28	2010-07-28	Egis Gyogyszergyar Nyilvanosan	Novel pharmaceutical use uf silicic acid
CN103961333B (zh) *	2014-05-07	2020-02-21	浙江华海药业股份有限公司	甲磺酸帕罗西汀胶囊及其制备方法
CN104027306A (zh) *	2014-06-25	2014-09-10	万特制药(海南)有限公司	帕罗西汀口服混悬液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1422263A (en) *	1973-01-30	1976-01-21	Ferrosan As	4-phenyl-piperidine compounds
EP0223403B1 (en) *	1985-10-25	1993-08-04	Beecham Group Plc	Piperidine derivative, its preparation, and its use as medicament
AR001982A1 (es) *	1995-02-06	1998-01-07	Smithkline Beecham Plc	Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
CA2206592A1 (en) *	1996-05-30	1997-11-30	Shu-Zhong Wang	Method of producing amorphous paroxetine hydrochloride

1998
- 1998-03-24 GB GBGB9806312.6A patent/GB9806312D0/en not_active Ceased
1999
- 1999-03-24 HU HU0101326A patent/HUP0101326A3/hu unknown
- 1999-03-24 NZ NZ506893A patent/NZ506893A/xx unknown
- 1999-03-24 AP APAP/P/2000/001914A patent/AP2000001914A0/en unknown
- 1999-03-24 BR BR9908991-2A patent/BR9908991A/pt not_active IP Right Cessation
- 1999-03-24 PL PL99343095A patent/PL343095A1/xx unknown
- 1999-03-24 JP JP2000537547A patent/JP2002507569A/ja active Pending
- 1999-03-24 TR TR2000/02750T patent/TR200002750T2/xx unknown
- 1999-03-24 EA EA200000977A patent/EA003393B1/ru not_active IP Right Cessation
- 1999-03-24 CA CA002324612A patent/CA2324612A1/en not_active Abandoned
- 1999-03-24 EP EP99911940A patent/EP1063993A1/en not_active Withdrawn
- 1999-03-24 IL IL13847899A patent/IL138478A0/xx unknown
- 1999-03-24 SK SK1410-2000A patent/SK14102000A3/sk unknown
- 1999-03-24 CN CN99804347A patent/CN1125639C/zh not_active Expired - Fee Related
- 1999-03-24 ID IDW20001883A patent/ID26485A/id unknown
- 1999-03-24 AU AU30451/99A patent/AU754765B2/en not_active Withdrawn - After Issue
- 1999-03-24 WO PCT/GB1999/000922 patent/WO1999048499A1/en not_active Ceased
2000
- 2000-09-22 NO NO20004740A patent/NO313404B1/no unknown
- 2000-10-16 BG BG104865A patent/BG104865A/xx unknown
- 2000-10-16 ZA ZA200005697A patent/ZA200005697B/xx unknown

Also Published As

Publication number	Publication date
CN1294512A (zh)	2001-05-09
NO313404B1 (no)	2002-09-30
ZA200005697B (en)	2001-10-02
BR9908991A (pt)	2000-12-12
TR200002750T2 (tr)	2000-12-21
HUP0101326A2 (hu)	2002-05-29
EA200000977A1 (ru)	2001-02-26
ID26485A (id)	2001-01-11
PL343095A1 (en)	2001-07-30
EA003393B1 (ru)	2003-04-24
WO1999048499A1 (en)	1999-09-30
AU754765B2 (en)	2002-11-21
IL138478A0 (en)	2001-10-31
CN1125639C (zh)	2003-10-29
AU3045199A (en)	1999-10-18
SK14102000A3 (sk)	2001-03-12
GB9806312D0 (en)	1998-05-20
JP2002507569A (ja)	2002-03-12
NO20004740D0 (no)	2000-09-22
HUP0101326A3 (en)	2002-06-28
CA2324612A1 (en)	1999-09-30
BG104865A (en)	2001-05-31
EP1063993A1 (en)	2001-01-03
NO20004740L (no)	2000-10-03
NZ506893A (en)	2003-06-30

Publication	Publication Date	Title
MY129356A (en)	2007-03-30	Electrospun pharmaceutical compositions
EP1004310A4 (en)	2005-01-19	GELED COMPOSITIONS
CA2284663A1 (en)	1998-10-22	Rapidly dissolving robust dosage form
PL321898A1 (en)	1997-12-22	Application of inorganic aerogles in pharmaceutics
HU9402238D0 (en)	1994-09-28	1-benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives, process for producing them and pharmaceutical compositions containing them
AP9801392A0 (en)	1998-12-31	Concentrated antibody preparation.
PL340906A1 (en)	2001-03-12	Adamantane derivatives
PL328465A1 (en)	1999-02-01	Administration dose form ibuprofen
IL110045A0 (en)	1994-10-07	Pharmaceutical compositions containing oligopeptides combating aids and arc and for immune stimulation and certain such novel oligopeptides
GEP20022752B (en)	2002-08-26	Valaciclovir Tablets Containing Colloidal Silicon Dioxide
NZ333724A (en)	2000-10-27	Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
HUP0203597A3 (en)	2005-07-28	Pharmaceutical compositions containing zolmitriptan, process for their preparation and their use
HUP0103381A3 (en)	2002-07-29	Disubstituted maleimide compounds and medicinal utilization thereof and the pharmaceutical compositions containing the same
AP2000001914A0 (en)	2000-09-30	Paroxetine compositions.
AP1901A (en)	2008-10-24	Pharmaceutical composition for modified release insulin sensitiser.
AU1671799A (en)	1999-06-16	Medicament preparation in the form of a tablet or pellet for acid-labile active substances
MY106371A (en)	1995-05-30	Oral pharmaceutical compositions in unit dosage form
MY120081A (en)	2005-08-30	Process for encapsulating shear sensitive fill masses into capsules and capsules containing shear sensitive fill masses
CA2348474A1 (en)	2000-05-18	Pharmaceutically active composition and dispensing device
AP2000002017A0 (en)	2000-12-31	Salts of paroxetine.
MX9709838A (es)	1998-08-30	Composiciones farmaceuticas estables que contienen hidratos de tiludronato y proceso para producir las composiciones farmaceuticas.
ZA939565B (en)	1994-08-11	Method for preparing low dose pharmaceutical products.
MX9703144A (es)	1998-02-28	Envase de seguridad frente a la accion de los niños para colocar parches portadores de principios activos.
HUT49320A (en)	1989-09-28	Process for producing ornithine derivatives and pharmaceutical compositions containing them as active components
AU2001274381A1 (en)	2002-01-30	A bioavailable dosage form of loratadine